Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study to Demonstrate Safety and Efficacy of E7777 in Persistent or Recurrent Cutaneous T-Cell Lymphoma

NCT01871727 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT01871727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01871727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study to Demonstrate Safety and Efficacy of E7777 in Persistent or Recurrent Cutaneous T-Cell Lymphoma
Lead sponsor
Eisai Inc.
Phase
Phase 3
Overall status
Completed
Start date
May 30, 2013
Completion date
December 14, 2021
Enrollment
112 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

persistent or recurrent cutaneous t-cell lymphoma